Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'

Llovet i Bayer, Josep MariaJohnson, Philip J.2018-04-032018-04-032014-03-200732-183Xhttps://hdl.handle.net/2445/1212352 p.application/pdfeng(c) American Society of Clinical Oncology, 2014Assaigs clínics de medicamentsCàncer de fetgeDrug testingLiver cancerReply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'info:eu-repo/semantics/article6456402018-04-03info:eu-repo/semantics/openAccess24516037